B-cells in systemic sclerosis: Emerging evidence from genetics to phenotypes

Minghua Wu, Chandra Mohan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose of review. This review aims to summarize current evidence for a role of B-cells in the pathogenesis of systemic sclerosis (SSc) from genetics to phenotypes, with an emphasis on recent insights. Recent findings. Multiple genomic analyses have associated several B-cell signalling genes with SSc. Moreover, interesting B-cell subset alterations and activation/memory marker changes have also been documented in SSc. Co-cultures of blood B-cells with dermal fibroblasts isolated from SSc patients demonstrated the induction of collagen, interleukin (IL)-6, transforming growth factor (TGF)-β1, IL-1β and chemokine (c-c motif) ligand 2 (CCL2) in the fibroblasts, following potential B-cell cues delivered to the fibroblasts. Plasma cell gene signatures were elevated in SSc patients' blood, and highly correlated with collagen gene expression. Finally, anti-CD20 B-cell depletion therapy not only improved skin disease but also preserved interstitial lung disease in early diffuse cutaneous disease. Summary. Thus, there is resounding evidence that B-cells play a pivotal role in pathogenesis of SSc. However, the molecular pathways through which B-cells may direct fibroblast function, SSc disease development and progression remain unclear, and warrant further study.

Original languageEnglish (US)
Pages (from-to)537-541
Number of pages5
JournalCurrent Opinion in Rheumatology
Volume27
Issue number6
DOIs
StatePublished - Nov 1 2015

Fingerprint

Systemic Scleroderma
B-Lymphocytes
Phenotype
Fibroblasts
Skin Diseases
Collagen
B-Lymphocyte Subsets
Interstitial Lung Diseases
Transforming Growth Factors
Cell- and Tissue-Based Therapy
Coculture Techniques
Plasma Cells
Interleukin-1
Chemokines
Genes
Cues
Disease Progression
Interleukin-6
Blood Cells
Ligands

Keywords

  • Antibodies
  • Autoimmunity
  • Cytokines
  • Fibrosis
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

B-cells in systemic sclerosis : Emerging evidence from genetics to phenotypes. / Wu, Minghua; Mohan, Chandra.

In: Current Opinion in Rheumatology, Vol. 27, No. 6, 01.11.2015, p. 537-541.

Research output: Contribution to journalArticle

Wu, Minghua ; Mohan, Chandra. / B-cells in systemic sclerosis : Emerging evidence from genetics to phenotypes. In: Current Opinion in Rheumatology. 2015 ; Vol. 27, No. 6. pp. 537-541.
@article{3df99db5d11d4a26b4ad248259403dec,
title = "B-cells in systemic sclerosis: Emerging evidence from genetics to phenotypes",
abstract = "Purpose of review. This review aims to summarize current evidence for a role of B-cells in the pathogenesis of systemic sclerosis (SSc) from genetics to phenotypes, with an emphasis on recent insights. Recent findings. Multiple genomic analyses have associated several B-cell signalling genes with SSc. Moreover, interesting B-cell subset alterations and activation/memory marker changes have also been documented in SSc. Co-cultures of blood B-cells with dermal fibroblasts isolated from SSc patients demonstrated the induction of collagen, interleukin (IL)-6, transforming growth factor (TGF)-β1, IL-1β and chemokine (c-c motif) ligand 2 (CCL2) in the fibroblasts, following potential B-cell cues delivered to the fibroblasts. Plasma cell gene signatures were elevated in SSc patients' blood, and highly correlated with collagen gene expression. Finally, anti-CD20 B-cell depletion therapy not only improved skin disease but also preserved interstitial lung disease in early diffuse cutaneous disease. Summary. Thus, there is resounding evidence that B-cells play a pivotal role in pathogenesis of SSc. However, the molecular pathways through which B-cells may direct fibroblast function, SSc disease development and progression remain unclear, and warrant further study.",
keywords = "Antibodies, Autoimmunity, Cytokines, Fibrosis, Systemic sclerosis",
author = "Minghua Wu and Chandra Mohan",
year = "2015",
month = "11",
day = "1",
doi = "10.1097/BOR.0000000000000215",
language = "English (US)",
volume = "27",
pages = "537--541",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - B-cells in systemic sclerosis

T2 - Emerging evidence from genetics to phenotypes

AU - Wu, Minghua

AU - Mohan, Chandra

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Purpose of review. This review aims to summarize current evidence for a role of B-cells in the pathogenesis of systemic sclerosis (SSc) from genetics to phenotypes, with an emphasis on recent insights. Recent findings. Multiple genomic analyses have associated several B-cell signalling genes with SSc. Moreover, interesting B-cell subset alterations and activation/memory marker changes have also been documented in SSc. Co-cultures of blood B-cells with dermal fibroblasts isolated from SSc patients demonstrated the induction of collagen, interleukin (IL)-6, transforming growth factor (TGF)-β1, IL-1β and chemokine (c-c motif) ligand 2 (CCL2) in the fibroblasts, following potential B-cell cues delivered to the fibroblasts. Plasma cell gene signatures were elevated in SSc patients' blood, and highly correlated with collagen gene expression. Finally, anti-CD20 B-cell depletion therapy not only improved skin disease but also preserved interstitial lung disease in early diffuse cutaneous disease. Summary. Thus, there is resounding evidence that B-cells play a pivotal role in pathogenesis of SSc. However, the molecular pathways through which B-cells may direct fibroblast function, SSc disease development and progression remain unclear, and warrant further study.

AB - Purpose of review. This review aims to summarize current evidence for a role of B-cells in the pathogenesis of systemic sclerosis (SSc) from genetics to phenotypes, with an emphasis on recent insights. Recent findings. Multiple genomic analyses have associated several B-cell signalling genes with SSc. Moreover, interesting B-cell subset alterations and activation/memory marker changes have also been documented in SSc. Co-cultures of blood B-cells with dermal fibroblasts isolated from SSc patients demonstrated the induction of collagen, interleukin (IL)-6, transforming growth factor (TGF)-β1, IL-1β and chemokine (c-c motif) ligand 2 (CCL2) in the fibroblasts, following potential B-cell cues delivered to the fibroblasts. Plasma cell gene signatures were elevated in SSc patients' blood, and highly correlated with collagen gene expression. Finally, anti-CD20 B-cell depletion therapy not only improved skin disease but also preserved interstitial lung disease in early diffuse cutaneous disease. Summary. Thus, there is resounding evidence that B-cells play a pivotal role in pathogenesis of SSc. However, the molecular pathways through which B-cells may direct fibroblast function, SSc disease development and progression remain unclear, and warrant further study.

KW - Antibodies

KW - Autoimmunity

KW - Cytokines

KW - Fibrosis

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84942508804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942508804&partnerID=8YFLogxK

U2 - 10.1097/BOR.0000000000000215

DO - 10.1097/BOR.0000000000000215

M3 - Article

C2 - 26285102

AN - SCOPUS:84942508804

VL - 27

SP - 537

EP - 541

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 6

ER -